PCM
CPXX

Prelude Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Prelude Capital Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-157,338
Closed -$4.75M – 2030
2016
Q2 		$4.75M Buy
157,338
+157,038
+52,346% +$3.19M 0.66% 20
2016
Q1 		$3K Buy
+300
New +$983 ﹤0.01% 1215

Prelude Capital Management's CPXX Position: Q3 2016 in Review

Prelude Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 157,338 shares — an estimated $4.75M sold.

Prelude Capital Management first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $4.75M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Prelude Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Prelude Capital Management sold 157,338 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $4.75M.
  • Prelude Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • Prelude Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $4.75M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Prelude Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.